Stay updated on Prophylactic Emicizumab in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Prophylactic Emicizumab in Hemophilia A Clinical Trial page.

Latest updates to the Prophylactic Emicizumab in Hemophilia A Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange Detected- Page revision updated from v3.3.1 to v3.3.2. No substantive changes to study details or navigation are evident.SummaryDifference0.0%

- Check21 days agoChange DetectedPublications section is updated to indicate items are automatically filled from PubMed and may not be about the study, and the page now shows Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the government funding status notice from the page; core study content such as eligibility, endpoints, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedThe new screenshot shows no meaningful edits to the study details; core information such as the study title, conditions, interventions, locations, eligibility criteria, and primary outcomes remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference1%

- Check79 days agoChange DetectedUpdate: standardize disease name to 'Hemophilia A' and bump revision to v3.1.0 to reflect an updated page version.SummaryDifference0.1%

Stay in the know with updates to Prophylactic Emicizumab in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prophylactic Emicizumab in Hemophilia A Clinical Trial page.